A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission: A report from the Children's Cancer Group

Blood

Volumn 97, Issue 1, 2001, Pages 56-62

  Woods, William G ^a   Neudorf, Steven ^b   Gold, Stuart ^b   Sanders, Jean ^b   Buckley, Jonathan D ^b   Barnard, Dorothy R ^b   Dusenbery, Kathryn ^b   DeSwarte, Joetta ^b   Arthur, Diane C ^b   Lange, Beverly J ^b   Kobrinsky, Nathan L ^b  

^a CHILDREN S ONCOLOGY GROUP   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER TOXICITY; LUNG TOXICITY; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME;

EID: 0035165636     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.1.56     Document Type: Article

References (25)

1. Intensive postremission chemotherapy in adults with acute myeloid leukemia
2. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia
3. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: A report from the Children's Cancer Group
4. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: A report from the Childrens Cancer Group
5. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission
6. Impact of high-dose cytarabine and asparaginase intensification on childhood acute myeloid leukemia: A report from the Childrens Cancer Group
7. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia
8. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia
9. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood
10. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: Results of the United Kingdom Medical Research Council's 10th AML trial
11. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission
12. Treatment of acute myeloid leukemia
13. Randomized comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRC AML 10 trial
14. Transplantation in first remission of acute myeloid leukemia
15. Aggressive post-remission chemotherapy is better than autologous bone marrow transplantation and allogeneic BMT is superior to both in children with acute myeloid leukemia
16. Autologous bone marrow transplantation in patients with acute non-lymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide
17. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: A Children's Cancer Group pilot study
18. Asymptotically efficient rank in variant test procedures
19. The errors of sampling the survivorship tables
20. Improvement in outcome for children with acute non-lymphocytic leukemia: A report from the Childrens Cancer Study Group
21. The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia
22. The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation
23. Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWIST analysis of the Pediatric Oncology Group Study 8821
24. Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission
25. Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission